Filtros de búsqueda

Lista de obras de Jia-Horng Kao

A comparison of hepatitis B viral markers of patients in different clinical stages of chronic infection.

artículo científico publicado en 2010

A noninvasive diagnosis of hepatic fibrosis by BioFibroScore® in chronic hepatitis C patients.

artículo científico publicado en 2017

A phase 3b study of sofosbuvir plus ribavirin in Taiwanese patients with chronic genotype 2 hepatitis C virus infection.

artículo científico publicado en 2016

A pilot study of add-on oral hypoglycemic agents in treatment-naïve genotype-1 chronic hepatitis C patients receiving peginterferon alfa-2b plus ribavirin

artículo científico publicado en 2014

A review of the burden of hepatitis C virus infection in China, Japan, South Korea and Taiwan.

artículo científico

APASL consensus statements and management algorithms for hepatitis C virus infection.

artículo científico

APASL consensus statements and recommendation on treatment of hepatitis C.

artículo científico publicado en 2016

APASL consensus statements and recommendations for hepatitis C prevention, epidemiology, and laboratory testing.

artículo científico publicado en 2016

APRI-M6 for predicting long-term outcome of chronic hepatitis C patients after interferon-based therapy: More questions than answers

artículo científico publicado en 2007

Aboriginal Taiwanese hepatitis B carriers have more favorable viral factors than Han Chinese carriers

artículo científico publicado en 2011

Acoustic Radiation Force Impulse US Imaging: Liver Stiffness in Patients with Chronic Hepatitis B with and without Antiviral Therapy

artículo científico publicado en 2018

Adipocytokines and liver fibrosis stages in patients with chronic hepatitis B virus infection.

artículo científico publicado en 2015

Advanced hepatic fibrosis and steatosis are associated with persistent alanine aminotransferase elevation in chronic hepatitis C patients negative for hepatitis C virus RNA during pegylated interferon plus ribavirin therapy

artículo científico publicado en 2014

Alisporivir with peginterferon/ribavirin in patients with chronic hepatitis C genotype 1 infection who failed to respond to or relapsed after prior interferon-based therapy: FUNDAMENTAL, a Phase II trial.

artículo científico publicado en 2014

All-oral daclatasvir plus asunaprevir for chronic hepatitis C virus (HCV) genotype 1b infection: a sub-analysis in Asian patients from the HALLMARK DUAL study

artículo científico publicado en 2016

All-oral daclatasvir plus asunaprevir for hepatitis C virus genotype 1b: a multinational, phase 3, multicohort study

artículo científico publicado en 2014

Alpha-fetoprotein in chronic hepatitis C

scientific article published on 19 October 2011

An update on non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in Asia.

artículo científico publicado en 2017

Antiandrogen hepatotoxicity in patients with chronic viral hepatitis

artículo científico publicado en 1999

Antiviral therapy against chronic hepatitis C is associated with a reduced risk of oral cancer

artículo científico publicado en 2019

Appropriate use of interferon for treatment of chronic hepatitis B.

artículo científico publicado en 2007

Artificial ascites is feasible and effective for difficult-to-ablate hepatocellular carcinoma.

artículo científico

Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.

artículo científico publicado en 2015

Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update

artículo científico publicado en 2012

Assessing the Durability of Entecavir-Treated Hepatitis B Using Quantitative HBsAg.

artículo científico publicado en 2016

Associated factors and clinical implications of serum aminotransferase elevation in scrub typhus

artículo científico publicado en 2014

Association Between Serum Level of Hepatitis B Surface Antigen at End of Entecavir Therapy and Risk of Relapse in E Antigen-Negative Patients

artículo científico publicado en 2016

Association of IL28B gene variations with mathematical modeling of viral kinetics in chronic hepatitis C patients with IFN plus ribavirin therapy ⬇️

artículo científico publicado el 14 de febrero de 2011

Association of IL28B genotypes with metabolic profiles and viral clearance rate in chronic hepatitis C patients.

artículo científico publicado en 2012

Association of SCARB1 Gene Polymorphisms with Virological Response in Chronic Hepatitis C Patients Receiving Pegylated Interferon plus Ribavirin Therapy.

artículo científico publicado en 2016

Association of chronic hepatitis B virus infection with insulin resistance and hepatic steatosis.

artículo científico publicado en 2007

Association of hepatitis C virus infection and malnutrition-inflammation complex syndrome in maintenance hemodialysis patients

artículo científico publicado en 2011

Association of lipid profiles with hepatitis C viral load in chronic hepatitis C patients with genotype 1 or 2 infection.

artículo científico publicado en 2009

Association of metabolic profiles with hepatic fibrosis in chronic hepatitis C patients with genotype 1 or 2 infection.

artículo científico publicado en 2010

Association of pre-S deletion mutant of hepatitis B virus with risk of hepatocellular carcinoma

artículo científico publicado en 2007

Asunaprevir-containing regimens for the treatment of hepatitis C virus infection.

artículo científico

Asymptomatic chronic hepatitis B virus infection does not increase the risk of diabetes mellitus: a ten-year observation.

artículo científico publicado en 2010

Basal core promoter T1762/A1764 and precore A1896 gene mutations in hepatitis B surface antigen-positive hepatocellular carcinoma: a comparison with chronic carriers.

artículo científico publicado en 2007

Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers.

artículo científico publicado en 2003

Baseline hepatitis B surface antigen quantitation can predict virologic response in entecavir-treated chronic hepatitis B patients.

artículo científico publicado en 2013

Benefits of long-term therapy with nucleos(t)ide analogues in treatment-naïve patients with chronic hepatitis B.

artículo científico publicado en 2016

Biphasic pattern of depression and its predictors during pegylated interferon-based therapy in chronic hepatitis B and C patients.

artículo científico publicado en 2012

Boceprevir for Chronic HCV Genotype 1 Infection ⬇️

artículo científico publicado el 14 de julio de 2011

Boceprevir-based triple therapy to rescue HCV genotype 1/HBV dually infected patients refractory to peginterferon plus ribavirin combination therapy in Taiwan.

artículo científico publicado en 2017

Both insulin resistance and alanine aminotransferase level increase the risks of cardiovascular disease in fatty liver disease.

artículo científico publicado en 2009

Can noninvasive biomarkers replace liver biopsy for chronic hepatitis B?

artículo científico publicado en 2015

Changes of soluble CD26 and CD30 levels correlate with response to interferon plus ribavirin therapy in patients with chronic hepatitis C.

artículo científico publicado en 2006

Changing disease burden of hepatocellular carcinoma in the Far East and Southeast Asia.

artículo científico publicado en 2005

Characterization of metastatic tumor antigen 1 and its interaction with hepatitis B virus X protein in NF-κB signaling and tumor progression in a woodchuck hepatocellular carcinoma model

scientific article published on 13 June 2016

Chronic hepatitis B is associated with an increased risk of B-cell non-Hodgkin's lymphoma and multiple myeloma

scientific article published on 25 January 2019

Chronic hepatitis C without anti-hepatitis C antibodies by second-generation assay

artículo científico publicado en 1996

Clinical Efficacy and Post-Treatment Seromarkers Associated with the Risk of Hepatocellular Carcinoma among Chronic Hepatitis C Patients.

artículo científico publicado en 2017

Clinical and Histologic Features of Patients with Biopsy-Proven Metabolic Dysfunction-Associated Fatty Liver Disease

artículo científico publicado en 2021

Clinical and Histologic Implications of Delayed Hepatobiliary Enhancement on Magnetic Resonance Imaging With Gadolinium Ethoxybenzyl Diethylenetriaminepentaacetic Acid ⬇️

artículo científico publicado el 1 de noviembre de 2012

Clinical and virological features of occult hepatitis B in patients with HBsAg seroclearance post-treatment or spontaneously.

artículo científico publicado en 2013

Clinical implications of hepatitis B virus variants.

artículo científico publicado en 2010

Clinical relevance of hepatitis B viral genotypes: a case of déjà vu?

artículo científico publicado en 2002

Clinical relevance of hepatitis B virus genotype in children with chronic infection and hepatocellular carcinoma

artículo científico publicado en 2004

Clinical significance and evolution of hepatic HBsAg expression in HBeAg-positive patients receiving interferon therapy

artículo científico publicado en 2013

Clinical significance of circulating miR-122 in patients with dual chronic hepatitis B and C virus infection.

artículo científico publicado en 2014

Clinical significance of occult hepatitis B virus infection cannot be overlooked.

artículo científico publicado en 2006

Clinical utility of quantitative HBsAg in natural history and nucleos(t)ide analogue treatment of chronic hepatitis B: new trick of old dog ⬇️

artículo científico publicado el 24 de octubre de 2012

Clinicopathological differences between hepatitis B viral genotype B- and C-related resectable hepatocellular carcinoma.

artículo científico publicado en 2007

Combination of hepatitis B viral factors and advanced liver disease in HBeAg-negative patients: the more, the worse?

scientific article published on 01 April 2008

Comorbidities, concomitant medications and potential drug-drug interactions with interferon-free direct-acting antiviral agents in hepatitis C patients in Taiwan

scientific article published on 25 October 2018

Comparison of Abbott RealTime HCV Genotype II with Versant line probe assay 2.0 for hepatitis C virus genotyping

artículo científico publicado en 2015

Comparison of two methods for quantification of hepatitis B viral DNA

artículo científico publicado en 1999

Consolidation therapy for HBeAg-positive Asian chronic hepatitis B patients receiving lamivudine treatment: a multicentre study

artículo científico publicado en 2013

Daclatasvir plus asunaprevir for HCV genotype 1b infection in patients with or without compensated cirrhosis: a pooled analysis.

artículo científico

Daclatasvir-containing all-oral regimens for the treatment of hepatitis C virus infection.

artículo científico publicado en 2015

Daclatasvir/Asunaprevir/Beclabuvir (DCV-TRIO), All-Oral, Fixed-Dose Combination for Patients With Chronic HCV Genotype 1.

artículo científico publicado en 2017

De novo assembly of highly polymorphic metagenomic data using in situ generated reference sequences and a novel BLAST-based assembly pipeline

artículo científico publicado en 2017

Diagnosis of hepatitis B virus infection through serological and virological markers.

artículo científico publicado en 2008

Direct-acting antivirals in East Asian hepatitis C patients: real-world experience from the REAL-C Consortium

scientific article published on 28 August 2019

Discontinuation of lamivudine treatment for hepatitis flare after kidney or heart transplantation in hepatitis B surface antigen-positive patients: A retrospective case series.

artículo científico publicado en 2006

Disease Progression in a Patient with Nonalcoholic Steatohepatitis

article

Distinct evolution and predictive value of hepatitis B virus precore and basal core promoter mutations in interferon-induced hepatitis B e antigen seroconversion.

artículo científico publicado en 2013

Distinct relapse rates and risk predictors after discontinuing tenofovir and entecavir therapy

artículo científico publicado en 2018

Dynamic contrast-enhanced magnetic resonance imaging with Gd-EOB-DTPA for the evaluation of liver fibrosis in chronic hepatitis patients ⬇️

artículo científico publicado el 31 de agosto de 2011

Dynamics of hepatitis B e antigen index ratio correlate with treatment response in chronic hepatitis B patients

article

Early antiviral therapy reduces the risk of lymphoma in patients with chronic hepatitis C infection

scientific article published on 27 December 2018

Early viral kinetics during treatment of chronic hepatitis C virus infection with pegylated interferon alpha plus ribavirin in Taiwan.

artículo científico publicado en 2007

East Asia expert opinion on treatment initiation for chronic hepatitis B

scientific article published on 20 September 2020

Editorial: comorbidities, concomitant medications and potential drug-drug interactions with interferon-free direct-acting anti-viral agents in chronic hepatitis C - authors' reply

artículo científico publicado en 2019

Editorial: increasing burden of nonalcoholic fatty liver disease-a call to action. Authors' reply

artículo científico publicado en 2020

Editorial: nephrotoxicity and oral anti-viral therapy for HBV-facts or fiction?

artículo científico publicado en 2019

Effect of host and viral factors on hepatitis B e antigen-positive chronic hepatitis B patients receiving pegylated interferon-α-2a therapy

artículo científico publicado en 2011

Effects of GB virus-C/hepatitis G virus on hepatitis B and C viremia in multiple hepatitis virus infections ⬇️

artículo científico publicado el 1 de enero de 1998

Effects of diabetes on the ED presentation of acute intermittent porphyria

artículo científico publicado en 2005

Effects of hepatitis B virus precore and basal core promoter mutations on the expression of viral antigens: genotype B vs C ⬇️

artículo científico publicado el 4 de julio de 2011

Efficacy and resistance to telbivudine treatment in chronic hepatitis B patients with favorable predictors: a multicenter study in Taiwan

artículo científico publicado en 2015

Efficacy of consensus interferon in the treatment of chronic hepatitis C.

artículo científico publicado en 2000

Efficacy of entecavir therapy for hepatitis B e-antigen positive chronic hepatitis B patients with prior exposure to interferon or nucleoside/nucleotide analogues.

artículo científico publicado en 2015

Elbasvir/grazoprevir for hepatitis C virus genotype 1b East-Asian patients receiving hemodialysis

artículo científico publicado en 2020

Elimination of Hepatitis B: Is It a Mission Possible?

artículo científico publicado en 2017

Erratum to: Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update

artículo científico publicado en 2012

Esophageal varices: noninvasive diagnosis with duplex Doppler US in patients with compensated cirrhosis.

artículo científico publicado en 2008

Evolution of Hepatitis B Serological Markers in HIV-Infected Patients Receiving Highly Active Antiretroviral Therapy

article

Evolution of Hepatitis B virus in an acute hepatitis B patient co-infected with genotypes B and C.

artículo científico publicado en 2006

Evolution of precore/core promoter mutations in hepatitis B carriers with hepatitis B e antigen seroreversion.

artículo científico publicado en 2004

Factors affecting the diagnostic accuracy of ultrasonography in assessing the severity of hepatic steatosis

scientific article published on 11 August 2012

Faldaprevir, pegylated interferon, and ribavirin for treatment-naïve HCV genotype-1: pooled analysis of two phase 3 trials

artículo científico publicado en 2016

Fibrosis index based on four factors better predicts advanced fibrosis or cirrhosis than aspartate aminotransferase/platelet ratio index in chronic hepatitis C patients.

artículo científico publicado en 2015

Fibrosis-4 Index Helps Identify HBV Carriers With the Lowest Risk of Hepatocellular Carcinoma.

artículo científico publicado en 2017

Fibrosis-4 index predicts cirrhosis risk and liver-related mortality in 2075 patients with chronic HBV infection.

artículo científico publicado en 2018

Fine mapping of hepatitis B virus pre-S deletion and its association with hepatocellular carcinoma.

artículo científico publicado en 2012

Fluvastatin helps interferon-based therapy in chronic hepatitis C: fact or fiction?

artículo científico publicado en 2013

Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients.

artículo científico publicado en 2016

From liver markers to life expectancy.

artículo científico publicado en 2010

GB virus C infection in hemodialysis patients: molecular evidence for nosocomial transmission

artículo científico publicado en 1999

GB virus C/hepatitis G virus infection in patients on continuous ambulatory peritoneal dialysis.

artículo científico publicado en 1998

GB virus-C/hepatitis G virus infection in an area endemic for viral hepatitis, chronic liver disease, and liver cancer.

artículo científico publicado en 1997

GB virus-C/hepatitis G virus infection in prostitutes: Possible role of sexual transmission ⬇️

artículo científico publicado el 1 de agosto de 1997

GBV-C in the aetiology of fulminant hepatitis.

artículo científico publicado en 1996

Gender Difference in the Association Between Metabolic Factors and Hepatocellular Carcinoma

artículo científico publicado en 2020

Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational study

scientific article published in Scientific Reports

Generic velpatasvir plus sofosbuvir for hepatitis C virus infection in patients with or without human immunodeficiency virus coinfection.

artículo científico publicado en 2018

Genetic variation in FCER1A predicts peginterferon alfa-2a-induced hepatitis B surface antigen clearance in East Asian patients with chronic hepatitis B

artículo científico publicado en 2019

Genomic variation-guided management in chronic hepatitis C.

artículo científico

Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection and severe renal impairment

scientific article published on 25 January 2020

Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection: Real-world effectiveness and safety in Taiwan

artículo científico publicado en 2019

Global control of hepatitis B virus infection.

artículo científico publicado en 2002

Global perspective on the natural history of chronic hepatitis B: role of hepatitis B virus genotypes A to J.

artículo científico

Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study

artículo científico publicado en 2016

HBV genotype and clinical outcome of chronic hepatitis B: facts and puzzles

artículo científico publicado en 2008

HBV genotypes and outcome of HBV infection.

artículo científico publicado en 2005

HBV markers for HCC prediction: Three heads are better than two?

scientific article published on 01 April 2017

HBV-DNA level at 6 months of entecavir treatment predicts HBeAg loss in HBeAg-positive chronic hepatitis B patients.

artículo científico publicado en 2013

HBV/A and HBV/C genotype predominance among patients with chronic hepatitis B virus infection in Cebu City, Philippines.

artículo científico publicado en 2011

HBeAg-positive chronic hepatitis B: why do I treat my patients with pegylated interferon?

artículo científico

HBsAg profiles in patients receiving peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses.

artículo científico publicado en 2010

HBsAg seroclearance: the more and earlier, the better

artículo científico publicado en 2009

HCV Cure Rates are Reduced in Patients with Active but not Inactive Hepatocellular Carcinoma- A Practice Implication

scientific article published on 28 November 2019

HCV core gene polymorphisms correlate with liver fibrosis but not sustained virological response in patients with genotype 1 infection.

artículo científico publicado en 2011

Hepatic necro-inflammation and elevated liver enzymes: evaluation with MRI perfusion imaging with gadoxetic acid in chronic hepatitis patients.

artículo científico publicado en 2014

Hepatitis B Surface Antigen Loss and Hepatocellular Carcinoma Development in Patients With Dual Hepatitis B and C Infection.

artículo científico publicado en 2016

Hepatitis B genotypes and precore/basal core promoter mutants in HBeAg-negative chronic hepatitis B

artículo científico publicado en 2002

Hepatitis B genotypes and the response to interferon therapy

article

Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B

artículo científico publicado en 2000

Hepatitis B genotypes correlate with tumor recurrence after curative resection of hepatocellular carcinoma.

artículo científico publicado en 2004

Hepatitis B post-partum e antigen clearance in hepatitis B carrier mothers: Correlation with viral characteristics

artículo científico publicado en 2006

Hepatitis B reactivation in patients receiving immunosuppressive therapy: a hidden menace

artículo científico publicado en 2017

Hepatitis B surface antigen level complements viral load in predicting viral reactivation in spontaneous HBeAg seroconverters

artículo científico publicado en 2014

Hepatitis B surface antigen quantification: why and how to use it in 2011 - a core group report

scientific article published on 28 June 2011

Hepatitis B vaccination and prevention of hepatocellular carcinoma.

artículo científico publicado en 2015

Hepatitis B vaccination: to boost or not to boost?

artículo científico publicado en 2005

Hepatitis B viral factors and clinical outcomes of chronic hepatitis B.

artículo científico publicado en 2007

Hepatitis B viral factors and treatment responses in chronic hepatitis B.

artículo científico publicado en 2013

Hepatitis B viral factors in HBeAg-Negative carriers with persistently normal serum alanine aminotransferase levels

scientific article published on 01 May 2007

Hepatitis B viral genotypes and lamivudine resistance.

artículo científico publicado en 2002

Hepatitis B viral genotypes: clinical relevance and molecular characteristics.

artículo científico publicado en 2002

Hepatitis B virus basal core promoter mutation and DNA load correlate with expression of hepatitis B core antigen in patients with chronic hepatitis B.

artículo científico publicado en 2009

Hepatitis B virus genotype B has an earlier emergence of lamivudine resistance than genotype C.

artículo científico publicado en 2009

Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men.

artículo científico publicado en 2005

Hepatitis B virus genotypes and hepatocellular carcinoma in Taiwan.

artículo científico publicado en 2003

Hepatitis B virus genotypes and variants.

artículo científico publicado en 2015

Hepatitis B virus infection and decreased risk of nonalcoholic fatty liver disease: A cohort study

artículo científico publicado en 2017

Hepatitis B virus infection and metabolic syndrome: fact or fiction?

artículo científico publicado en 2015

Hepatitis B virus mutants associated with hepatitis B surface antigen loss: chicken or egg?

artículo científico publicado en 2012

Hepatitis B virus reactivation in patients receiving cancer chemotherapy: natural history, pathogenesis, and management

artículo científico publicado en 2011

Hepatitis B virus: new therapeutic perspectives.

artículo científico publicado en 2016

Hepatitis C Virus Infection and Chronic Active Myocarditis ⬇️

artículo científico publicado el 8 de septiembre de 1998

Hepatitis C and G Virus infections in polytransfused children ⬇️

artículo científico publicado el 1 de julio de 1997

Hepatitis C infection and metabolic syndrome.

artículo científico publicado en 2010

Hepatitis C viral infection increases the risk of lymphoid-neoplasms: A population-based cohort study.

artículo científico publicado en 2015

Hepatitis C virus and lipid profiles: more questions than answers? ⬇️

artículo científico publicado el 29 de julio de 2011

Hepatitis C virus reinfection in people living with human immunodeficiency virus in Taiwan after achieving sustained virologic response with antiviral treatment: the RECUR study

artículo científico publicado en 2022

Hepatitis D virus genotypes in intravenous drug users in taiwan: decreasing prevalence and lack of correlation with hepatitis B virus genotypes.

artículo científico publicado en 2002

Hepatitis G Virus Infection in Normal and Prospectively Followed Posttransfusion Children ⬇️

artículo científico publicado el 1 de diciembre de 1997

Hepatitis during antituberculosis treatment

artículo científico publicado en 2011

Hepatobiliary and Pancreatic: Biliary hamartoma manifests as liver cysts

scientific article published on 11 November 2019

Heterogeneity of hereditary persistence of alpha-fetoprotein

scientific article published on 01 August 2004

High Levels of Hepatitis B Surface Antigen Increase Risk of Hepatocellular Carcinoma in Patients With Low HBV Load ⬇️

artículo científico publicado el 11 de febrero de 2012

High Serum Lipopolysaccharide-Binding Protein Level in Chronic Hepatitis C Viral Infection Is Reduced by Anti-Viral Treatments

artículo científico publicado en 2017

High hepatitis C viral load is associated with insulin resistance in patients with chronic hepatitis C.

artículo científico publicado en 2007

High prevalence of mixed genotype infections in hepatitis B virus infected intravenous drug users.

artículo científico publicado en 2004

Higher adherence with 3-year entecavir treatment than lamivudine or telbivudine in treatment-naïve Taiwanese patients with chronic hepatitis B.

artículo científico publicado en 2014

Higher cut-off index value of immunoglobulin M antibody to hepatitis B core antigen in Taiwanese patients with hepatitis B

artículo científico publicado en 2006

Higher lifetime chance of spontaneous surface antigen loss in hepatitis B carriers with genotype C infection

artículo científico publicado en 2015

Higher proportion of viral basal core promoter mutant increases the risk of liver cirrhosis in hepatitis B carriers.

artículo científico publicado en 2014

Historical epidemiology of hepatitis C virus in select countries—volume 4

artículo científico publicado en 2017

Host genetic factors affecting spontaneous HBsAg seroclearance in chronic hepatitis B patients

artículo científico publicado en 2013

Host genetic variants and hepatitis B virologic features in HBeAg-negative hepatitis B carriers with long-term biochemical remission ⬇️

artículo científico publicado el 21 de julio de 2011

How have the recent advances in antiviral therapy impacted the management of virus-related hepatocellular carcinoma?

artículo científico publicado en 2016

Human leukocyte antigen-DRB1*1101 correlates with less severe hepatitis in Taiwanese male carriers of hepatitis B virus.

artículo científico publicado en 2009

Hypercholesterolemia in primary biliary cirrhosis

artículo científico publicado en 2007

IL-10 promoter gene polymorphisms and sustained response to combination therapy in Taiwanese chronic hepatitis C patients.

artículo científico publicado en 2008

IL-21R gene polymorphisms and serum IL-21 levels predict virological response to interferon-based therapy in Asian chronic hepatitis C patients.

artículo científico publicado en 2013

IL-28B predicts response to chronic hepatitis C therapy--fine-mapping and replication study in Asian populations.

artículo científico publicado en 2011

Immune response to a hepatitis C virus nonstructural protein in chronic hepatitis C virus infection.

artículo científico publicado en 1994

Immunoglobulin M antibodies against hepatitis C virus antigens: significance and applications.

artículo científico publicado en 1993

Impact of hepatitis B virus infection on metabolic profiles and modifying factors.

artículo científico publicado en 2011

Impact of hepatitis D virus infection on the long-term outcomes of patients with hepatitis B virus and HIV coinfection in the era of highly active antiretroviral therapy: a matched cohort study.

artículo científico publicado en 2007

Impact of occult hepatitis B on the clinical outcomes of patients with chronic hepatitis C virus infection: A 10-year follow-up

artículo científico publicado en 2016

Improving clinical outcomes of chronic hepatitis B virus infection.

artículo científico

In memoriam: Dr. Ding-Shinn Chen, 1943-2020

artículo científico publicado en 2020

Incidence and clinical presentation of posttransfusion TT virus infection in prospectively followed transfusion recipients: emphasis on its relevance to hepatitis.

artículo científico publicado en 2000

Incorporating Serum Level of Hepatitis B Surface Antigen or Omitting Level of Hepatitis B Virus DNA Does not Affect Calculation of Risk for Hepatocellular Carcinoma in Patients Without Cirrhosis.

artículo científico publicado en 2015

Increased incidence of gastroesophageal reflux disease in patients with chronic hepatitis B virus infection ⬇️

artículo científico publicado el 1 de julio de 2010

Increased risk of cirrhosis and its decompensation in chronic hepatitis B patients with newly diagnosed diabetes: a nationwide cohort study

artículo científico publicado en 2013

Increased risk of cirrhosis and its decompensation in chronic hepatitis C patients with new-onset diabetes: a nationwide cohort study

artículo científico publicado en 2014

Increased risk of hepatocellular carcinoma in chronic hepatitis C patients with new onset diabetes: a nation-wide cohort study.

artículo científico publicado en 2015

Influence of hepatitis C virus infection on soluble cellular adhesion molecules in hemodialysis patients.

artículo científico publicado en 2005

Interferon alpha-2b with and without ribavirin in the treatment of hepatitis B e antigen-positive chronic hepatitis B: a randomized study.

artículo científico publicado en 2006

Interferon-alpha reduces insulin resistance and beta-cell secretion in responders among patients with chronic hepatitis B and C.

artículo científico publicado en 2003

Interferon-based therapy decreases risks of hepatocellular carcinoma and complications of cirrhosis in chronic hepatitis C patients.

artículo científico publicado en 2013

Interferon-based therapy for dialysis patients with chronic hepatitis C: progress and challenges

artículo científico publicado en 2007

Interferon-based therapy reduces risk of stroke in chronic hepatitis C patients: a population-based cohort study in Taiwan.

artículo científico publicado en 2013

Interleukin 28B genetic polymorphisms and viral factors help identify HCV genotype-1 patients who benefit from 24-week pegylated interferon plus ribavirin therapy.

artículo científico publicado en 2011

Interleukin 28B genetic polymorphisms play a minor role in identifying optimal treatment duration in HCV genotype 1 slow responders to pegylated interferon plus ribavirin.

artículo científico publicado en 2012

Intrafamilial transmission of hepatitis B virus infection.

artículo científico publicado en 2007

Intrathecal delivery of a mutant micro-opioid receptor activated by naloxone as a possible antinociceptive paradigm.

artículo científico publicado en 2010

Lamivudine treatment for hepatitis B reactivation in HBsAg carriers after organ transplantation: a 4-year experience.

artículo científico publicado en 2001

Least microtransfusion from mother to fetus in elective cesarean delivery.

artículo científico publicado en 1996

Ledipasvir/sofosbuvir fixed-dose combination tablet in Taiwanese patients with chronic genotype 1 hepatitis C virus.

artículo científico publicado en 2016

Letter: contraindicated drug-drug interactions before and after initiation of direct-acting anti-viral agents in chronic hepatitis C patients in Taiwan. Authors' reply

scientific article published on 01 July 2019

Letter: elevated HBV DNA predicts poor survival in hepatocellular carcinoma after hepatic resection-authors' reply

artículo científico publicado en 2021

Letter: elevated aspartate aminotransferase and aspartate aminotransferase to alanine aminotransferase ratio predicts poor survival in hepatocellular carcinoma after resection-Authors' reply

artículo científico publicado en 2020

Letter: hepatic steatosis and fibrosis in chronic hepatitis B—the chicken‐and‐egg conundrum

artículo científico publicado en 2021

Letter: hepatitis B virus infection and risk of multiple myeloma-a meta-analysis of cohort studies. Authors' reply

artículo científico publicado en 2020

Letter: the influence of direct acting agents for hepatitis C, on hepatitis B reactivation.

artículo científico publicado en 2017

Liver Gene Expression Profiles Correlate with Virus Infection and Response to Interferon Therapy in Chronic Hepatitis B Patients

artículo científico publicado en 2016

Liver and peripheral blood mononuclear cells are not major sites for GB virus-C/hepatitis G virus replication.

artículo científico publicado en 1999

Local ablation vs. resection for the treatment of hepatocellular carcinoma

artículo científico publicado en 2006

Long-term effect of interferon plus ribavirin on hepatitis B surface antigen seroclearance in patients dually infected with hepatitis B and C viruses.

artículo científico publicado en 2011

Longitudinal change of HBsAg in HBeAg-negative patients with genotype B or C infection

artículo científico publicado en 2013

Looking into the crystal ball: biomarkers for outcomes of HBV infection.

artículo científico publicado en 2016

Low prevalence of hepatitis C virus infection among dentists in Taiwan ⬇️

artículo científico publicado el 1 de mayo de 1993

Management of hepatitis C patients with decompensated liver disease.

artículo científico publicado en 2016

Medical Treatment of Fish Bone-Related Liver Abscess

artículo científico publicado en 2005

Metabolic syndrome on top of chronic hepatitis B: the more, the worse?

scientific article published on 01 February 2010

Micro-evolution of the hepatitis B virus genome in hepatitis B e-antigen-positive carriers: comparison of genotypes B and C at various immune stages.

artículo científico publicado en 2015

Milder clinical manifestation of scrub typhus in Kinmen, Taiwan

artículo científico publicado en 2012

Molecular Epidemiology of Hepatitis B Viral Serotypes and Genotypes in Taiwan

artículo científico publicado en 2002

Molecular Epidemiology of Hepatitis B Virus ⬇️

artículo científico publicado el 13 de septiembre de 2011

Molecular mechanism and treatment of viral hepatitis-related liver fibrosis

artículo científico publicado en 2014

More viral mutants, less HBsAg clearance? One size may not fit all.

artículo científico publicado en 2016

NIACE score refines the overall survival of hepatocellular carcinoma by Barcelona clinic liver cancer staging

scientific article published on 18 June 2019

NOhep: Toward Global Control of Hepatitis B Virus Infection-An Introduction

artículo científico publicado en 2017

Nanomedicines in the treatment of hepatitis C virus infection in Asian patients: optimizing use of peginterferon alfa

artículo científico publicado en 2014

Natural history of acute and chronic hepatitis B: The role of HBV genotypes and mutants.

artículo científico publicado en 2017

New insights into the evolutionary rate of hepatitis B virus at different biological scales

artículo científico publicado en 2015

New perspectives of biomarkers for the management of chronic hepatitis B.

artículo científico publicado en 2016

No Evidence of Reactivation of Hepatitis B Virus Among Patients Treated With Ledipasvir-Sofosbuvir for Hepatitis C Virus Infection.

artículo científico publicado en 2016

Non-alcoholic fatty liver disease: an emerging liver disease in Taiwan

artículo científico publicado en 2012

Noninvasive Diagnosis of Hepatic Fibrosis in Patients With Chronic Hepatitis C by Splenic Doppler Impedance Index

scientific article published on 01 October 2007

Noninvasive tests for the prediction of significant hepatic fibrosis in hepatitis C virus carriers with persistently normal alanine aminotransferases.

artículo científico publicado en 2006

Nucleos(t)ide analogues in patients with chronic hepatitis B: to stop or not to stop?

scientific article published on 16 September 2019

Occult hepatitis B virus infection and clinical outcomes of patients with chronic hepatitis C

artículo científico publicado en 2002

On-treatment low serum HBV RNA level predicts initial virological response in chronic hepatitis B patients receiving nucleoside analogue therapy.

artículo científico publicado en 2014

Optimal management of hepatocellular carcinoma: challenges and opportunities.

artículo científico publicado en 2010

Origin of serum hepatitis B virus in acute exacerbation: comparison with HBV in the liver and from other exacerbation.

artículo científico publicado en 2004

Outcomes of HCV treatment: who does well and who does not?

artículo científico publicado en 2010

Overlap lamivudine treatment in patients with chronic hepatitis B receiving adefovir for lamivudine-resistant viral mutants

artículo científico publicado en 2006

Paratyphoid hepatitis: an emerging clinical entity.

artículo científico publicado en 2002

Paritaprevir/ritonavir, ombitasvir plus dasabuvir for East Asian non-cirrhotic hepatitis C virus genotype 1b patients receiving hemodialysis

artículo científico publicado en 2019

Peginterferon Lambda-1a/Ribavirin with Daclatasvir or Peginterferon Alfa-2a/Ribavirin with Telaprevir for Chronic Hepatitis C Genotype 1b.

artículo científico publicado en 2016

Peginterferon alfa-2a plus Weight-Based or Flat-Dose Ribavirin for Treatment-Naïve Hepatitis C Virus Genotype 2 Rapid Responders: A Randomized Trial

artículo científico publicado en 2015

Peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses

artículo científico publicado en 2008

Peginterferon alfa-2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 2 receiving haemodialysis: a randomised trial

artículo científico publicado en 2014

Peginterferon alfa-2b or alfa-2a with ribavirin for hepatitis C.

artículo científico publicado en 2009

Peginterferon plus Ribavirin for HIV-infected Patients with Treatment-Naïve Acute or Chronic HCV Infection in Taiwan: A Prospective Cohort Study.

artículo científico publicado en 2015

Peginterferon plus weight-based ribavirin for treatment-naïve hepatitis C virus genotype 2 patients not achieving rapid virologic response: a randomized trial

artículo científico publicado en 2015

Peginterferon α in the treatment of chronic hepatitis B.

artículo científico

Pegylated IFN-α suppresses hepatitis C virus by promoting the DAPK-mTOR pathway.

artículo científico publicado en 2016

Pegylated interferon alfa-2a monotherapy for hemodialysis patients with acute hepatitis C.

artículo científico publicado en 2010

Pegylated interferon alpha-2a plus low-dose ribavirin for the retreatment of dialysis chronic hepatitis C patients who relapsed from prior interferon monotherapy.

artículo científico publicado en 2009

Pegylated interferon-alpha-2a plus ribavirin for treatment-naive Asian patients with hepatitis C virus genotype 1 infection: a multicenter, randomized controlled trial.

artículo científico publicado en 2008

Percutaneous ethanol injection versus surgical resection for the treatment of small hepatocellular carcinoma: a prospective study.

artículo científico publicado en 2005

Persistence of hepatitis B virus covalently closed circular DNA in hepatocytes: molecular mechanisms and clinical significance.

artículo científico publicado en 2014

Persistent hepatitis B viral replication in a FVB/N mouse model: impact of host and viral factors

artículo científico publicado en 2012

Perspectives and control of hepatitis B virus infection in Taiwan.

artículo científico

Perspectives on dual hepatitis B and C infection in Taiwan

artículo científico publicado en 2016

Phase IV randomized clinical study: Peginterferon alfa-2a with adefovir or entecavir pre-therapy for HBeAg-positive chronic hepatitis B.

artículo científico publicado en 2018

Plasma adipokines and risk of hepatocellular carcinoma in chronic hepatitis B virus-infected carriers: a prospective study in taiwan

artículo científico publicado en 2014

Positive and negative strand of hepatitis C virus RNA sequences in peripheral blood mononuclear cells in patients with chronic hepatitis C: no correlation with viral genotypes 1b, 2a, and 2b

artículo científico publicado el 1 de julio de 1997

Post-partum acute exacerbation of chronic hepatitis in a hepatitis C-carrier mother.

artículo científico publicado en 2001

Predicting Hepatitis B Virus (HBV) Surface Antigen Seroclearance in HBV e Antigen-Negative Patients With Chronic Hepatitis B: External Validation of a Scoring System

artículo científico publicado en 2014

Prevalence and clinical implications of HFE gene mutations (C282Y and H63D) in patients with chronic hepatitis B and C in Taiwan.

artículo científico publicado en 2005

Prevalence and clinical implications of IL28B genotypes in Taiwanese patients with chronic hepatitis C.

artículo científico publicado en 2016

Prevalence and implication of a newly identified infectious agent (SEN virus) in Taiwan.

artículo científico publicado en 2002

Prevention of hepatocellular carcinoma in hepatitis B virus infection.

scientific article published on August 2009

Prevention of mother-to-child transmission: the key of hepatitis B virus elimination

article

Profound week 4 interferon responsiveness is mandatory for hepatitis C genotype 1 patients with unfavorable IL-28B genotype ⬇️

artículo científico publicado el 1 de abril de 2013

Progress towards elimination goals for viral hepatitis

scientific article published on 23 July 2020

Prothrombin induced by vitamin K absence or antagonist-II (PIVKA-II) predicts complete responses of transarterial chemoembolization for hepatocellular carcinoma

artículo científico publicado en 2022

Quantification and genotyping of hepatitis B virus in a single reaction by real-time PCR and melting curve analysis

artículo científico publicado en 2004

Quantification of Hepatitis B Core Antibody Helps Predict Clinical Relapse After Cessation of Nucleos(t)ide Analogues in Chronic Hepatitis B Patients: More Needs to Be Done

scientific article published on 01 April 2019

Quantification of serum hepatitis B core antibody to predict off-entecavir relapse in patients with chronic hepatitis B.

artículo científico publicado en 2017

Quantitative hepatitis B core antibody level may help predict treatment response in chronic hepatitis B patients.

artículo científico publicado en 2012

Quantitative hepatitis B core antibody levels in the natural history of hepatitis B virus infection

artículo científico publicado en 2014

Reactivation of hepatitis B virus in an inactive hepatitis B carrier with glucocorticoid pulse therapy.

artículo científico publicado en 2008

Real-world effectiveness and safety of sofosbuvir and ledipasvir with or without ribavirin for patients with hepatitis C virus genotype 1 infection in Taiwan

artículo científico publicado en 2018

Real-world effectiveness of direct-acting antiviral agents for chronic hepatitis C in Taiwan: Real-world data

artículo científico publicado en 2018

Recent advances in clinical application of gut hormones.

artículo científico publicado en 2010

Recent advances in the treatment of chronic hepatitis B.

scientific article published on 20 June 2011

Reduced Toll-like receptor 3 expression in chronic hepatitis B patients and its restoration by interferon therapy.

artículo científico publicado en 2013

Reduced toll-like receptor 9 expression on peripheral CD14+ monocytes of chronic hepatitis B patients and its restoration by effective therapy.

artículo científico publicado en 2014

Reimbursement policies in the Asia-Pacific for chronic hepatitis B.

artículo científico publicado en 2014

Relation of Chlamydia pneumoniae infection in Taiwan to angiographically demonstrated coronary artery disease and to the presence of acute myocardial infarction or unstable angina pectoris.

artículo científico publicado en 2001

Reply

artículo científico publicado en 2016

Reply to Guedj et al.: Early transient increase of hepatitis C virus viral load in genotype 1 and 2 infections, and the use of mathematical modeling.

artículo científico publicado en 2011

Response to Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients.

artículo científico publicado en 2017

Review article: novel therapies for hepatitis B virus cure - advances and perspectives.

artículo científico publicado en 2016

Review article: the prevention of hepatitis B-related hepatocellular carcinoma

scientific article published on 03 May 2018

Revisiting the stopping rule for hepatitis C genotype 1 patients treated with peginterferon plus ribavirin

artículo científico publicado en 2012

Ribavirin and interferon is effective for hepatitis C virus clearance in hepatitis B and C dually infected patients

artículo científico publicado en 2003

Risk factors of hepatitis during anti-tuberculous treatment and implications of hepatitis virus load.

artículo científico publicado en 2011

Risk stratification for hepatitis B virus related hepatocellular carcinoma ⬇️

artículo científico publicado el 1 de enero de 2013

Risk stratification of HBV infection in Asia-Pacific region.

artículo científico publicado en 2014

Risk stratification of hepatocellular carcinoma in hepatitis B virus e antigen-negative carriers by combining viral biomarkers.

artículo científico publicado en 2013

Ritonavir-boosted danoprevir plus peginterferon alfa-2a and ribavirin in Asian chronic hepatitis C patients with or without cirrhosis.

artículo científico publicado en 2016

Role of hepatitis B virus precore/core promoter mutations and serum viral load on noncirrhotic hepatocellular carcinoma: a case-control study.

artículo científico publicado en 2006

SEN virus infection in patients with chronic hepatitis C: preferential coinfection with hepatitis C genotype 2a and no effect on response to therapy with interferon plus ribavirin.

artículo científico publicado en 2002

Secular trend of age-specific prevalence of hepatitis B surface and e antigenemia in pregnant women in Taiwan

scholarly article by Ho-Hsiung Lin published in February 2003

Secular trend of the viral genotype distribution in children with chronic hepatitis B virus infection after universal infant immunization.

artículo científico publicado en 2011

Sequence analysis of pre-S/surface and pre-core/core promoter genes of hepatitis B virus in chronic hepatitis C patients with occult HBV infection.

artículo científico publicado en 2002

Sequential combination therapy for chronic hepatitis B: more challenges to be tackled

scientific article published on 01 July 2007

Serine/threonine protein phosphatase 5 is a potential therapeutic target in cholangiocarcinoma.

artículo científico publicado en 2018

Serum Biomarkers Predictive of Significant Fibrosis and Cirrhosis in Chronic Hepatitis B.

artículo científico publicado en 2014

Serum Hepatitis B Surface Antigen Levels Help Predict Disease Progression in Patients With Low Hepatitis B Virus Loads ⬇️

artículo científico publicado el 6 de diciembre de 2012

Serum Mac-2-Binding Protein Glycosylation Isomer at Virological Remission Predicts Hepatocellular Carcinoma and Death in Chronic Hepatitis B-Related Cirrhosis

artículo científico publicado en 2020

Serum adiponectin correlates with viral characteristics but not histologic features in patients with chronic hepatitis C.

artículo científico publicado en 2005

Serum cytokine/chemokine profiles in acute exacerbation of chronic hepatitis B: clinical and mechanistic implications.

artículo científico publicado en 2014

Serum hepatitis B surface antigen concentration correlates with HBV DNA level in patients with chronic hepatitis B.

artículo científico publicado en 2010

Serum hepatitis B surface antigen levels predict surface antigen loss in hepatitis B e antigen seroconverters.

artículo científico publicado en 2011

Serum hepatitis B virus-DNA levels correlate with long-term adverse outcomes in spontaneous hepatitis B e antigen seroconverters.

artículo científico publicado en 2011

Serum hepatitis C virus titers in the progression of type C chronic liver disease. With special emphasis on patients with type 1b infection.

artículo científico publicado en 1996

Serum interleukin 6 level correlates with outcomes of acute exacerbation of chronic hepatitis B

artículo científico publicado en 2011

Serum p53 gene polymorphisms and severity of hepatitis B or C-related chronic liver diseases in Taiwan

article

Serum viral load at the virological relapse predicts subsequent clinical flares in chronic hepatitis B patients off entecavir therapy.

artículo científico publicado en 2017

Severity of fatty liver on ultrasound correlates with metabolic and cardiovascular risk

artículo científico publicado en 2012

Significance of definitions of relapse after discontinuation of oral antivirals in HBeAg-negative chronic hepatitis B.

artículo científico publicado en 2017

Slow decline of hepatitis B burden in general population: Results from a population-based survey and longitudinal follow-up study in Taiwan.

artículo científico publicado en 2015

Sofosbuvir and ledipasvir are associated with high sustained virologic response and improvement of health-related quality of life in East Asian patients with hepatitis C virus infection

scholarly article by Zobair M. Younossi published in July 2018

Sofosbuvir-based interferon-free direct acting antiviral regimens for heart transplant recipients with chronic hepatitis C virus infection.

artículo científico publicado en 2017

Sofosbuvir/velpatasvir with or without low-dose ribavirin for patients with chronic hepatitis C virus infection and severe renal impairment

scientific article published on 06 January 2021

Sorafenib and its derivative SC-1 exhibit antifibrotic effects through signal transducer and activator of transcription 3 inhibition

artículo científico publicado en 2015

Src-homology protein tyrosine phosphatase-1 agonist, SC-43, reduces liver fibrosis.

artículo científico publicado en 2017

Strategies to manage hepatitis C virus infection disease burden—Volume 4

artículo científico publicado en 2017

Subgenotypes of hepatitis B virus genotype C do not correlate with disease progression of chronic hepatitis B in Taiwan.

artículo científico publicado en 2007

Subgenotypes of hepatitis B virus genotype C in Taiwan.

artículo científico publicado en 2005

Successful Antiviral Therapy Reduces Risk of Schizophrenia Among Chronic Hepatitis C Patients: A Nationwide Real-World Taiwanese Cohort (T-COACH)

artículo científico publicado en 2020

Successful treatment of chronic hepatitis B and D with pegylated-interferon plus entecavir.

artículo científico publicado en 2013

Surveillance of Hepatocellular Carcinoma by Magnetic Resonance Imaging With Liver-Specific Contrast

artículo científico publicado en 2017

Sustained hepatitis C virus clearance and increased hepatitis B surface antigen seroclearance in patients with dual chronic hepatitis C and B during posttreatment follow-up ⬇️

artículo científico publicado el 26 de abril de 2013

Sustained virological response to hepatitis C therapy does not decrease the incidence of systemic lupus erythematosus or rheumatoid arthritis

scientific article published on 25 March 2020

Systematic Review: Impact of Interferon-based Therapy on HCV-related Hepatocellular Carcinoma

artículo científico publicado en 2015

Systematic review: chronic viral hepatitis and metabolic derangement

artículo científico publicado en 2019

TT virus infection in healthy children, children after blood transfusion, and children with non-A to E hepatitis or other liver diseases in Taiwan

artículo científico publicado en 2003

Targeting SHP-1-STAT3 signaling: A promising therapeutic approach for the treatment of cholangiocarcinoma

artículo científico publicado en 2017

Telbivudine therapy for chronic hepatitis B: A journey to identify super-responders and to optimize treatment using the roadmap model

artículo científico

The CRISPR/Cas9 System Facilitates Clearance of the Intrahepatic HBV Templates In Vivo

artículo científico publicado en 2014

The Effects of Metabolic SyndromeVersusInfectious Burden on Inflammation, Severity of Coronary Atherosclerosis, and Major Adverse Cardiovascular Events

artículo científico publicado en 2007

The clinical implications of hepatitis B virus genotype: Recent advances.

artículo científico publicado en 2011

The clinical significance of occult hepatitis B transfusion in Taiwan--a look-back study.

artículo científico

The non-structural 5A protein of hepatitis C virus exhibits genotypic differences in interferon antagonism.

artículo científico publicado en 2008

The present and future disease burden of hepatitis C virus infections with today's treatment paradigm: Volume 4

artículo científico publicado en 2017

The ratio of aminotransferase to platelets is a useful index for predicting hepatic fibrosis in hemodialysis patients with chronic hepatitis C.

artículo científico publicado en 2010

Therapeutic implications of hepatitis B virus genotypes.

artículo científico publicado en 2005

Time-varying serum gradient of hepatitis B surface antigen predicts risk of relapses after off-NA therapy.

artículo científico publicado en 2017

To genotype or not to genotype: toward an optimal tailoring of treatment of chronic hepatitis B

scientific article published on 01 June 2007

Towards an HBV cure: state-of-the-art and unresolved questions--report of the ANRS workshop on HBV cure.

artículo científico publicado en 2015

Transient elastography to assess hepatic fibrosis in hemodialysis chronic hepatitis C patients.

artículo científico publicado en 2011

Transmission of occult hepatitis B virus by transfusion to adult and pediatric recipients in Taiwan

artículo científico publicado en 2005

Treating Immune-tolerant Hepatitis B.

artículo científico publicado en 2014

Treatment of chronic hepatitis B in Asia-Pacific countries: is the Asia-Pacific consensus statement being followed?

artículo científico publicado en 2010

Treatment of de novo hepatitis C virus-related fibrosing cholestatic hepatitis after orthotopic heart transplantation by ledipasvir and sofosbuvir

artículo científico publicado en 2017

Treatment of hepatitis C virus infection in patients with end-stage renal disease.

artículo científico publicado en 2011

Two decades of universal hepatitis B vaccination in taiwan: impact and implication for future strategies

artículo científico publicado en 2007

Typhoid fever and typhoid hepatitis in Taiwan.

artículo científico publicado en 2005

Uncovered issues in the overview of nonalcoholic steatohepatitis

scientific article published on 23 December 2011

Universal Hepatitis B Vaccination: Killing 2 Birds with 1 Stone

artículo científico publicado en 2008

Universal hepatitis B vaccination and the decreased mortality from fulminant hepatitis in infants in Taiwan.

artículo científico publicado en 2001

Unmet Needs in Clinical and Basic Hepatitis B Virus Research.

artículo científico publicado en 2017

Urgency to treat patients with chronic hepatitis C in Asia

artículo científico publicado en 2016

Uridine diphosphate glucuronosyl transferase 1A1 promoter polymorphism is associated with choledocholithiasis in Taiwanese patients

scientific article published on 28 May 2009

Value of interleukin-28B genetic polymorphism on retreatment outcomes of chronic hepatitis C genotype 1 relapsers by peginterferon alfa plus ribavirin.

artículo científico publicado en 2014

Vascular and hepatic enhancements at MR imaging: comparison of Gd-EOB-DTPA and Gd-DTPA in the same subjects

scientific article published on 13 January 2014

Viral hepatitis. HBV cure--can we pin our hopes on immunotherapy?

artículo científico publicado en 2015

Viral load and alanine aminotransferase correlate with serologic response in chronic hepatitis B patients treated with entecavir

artículo científico publicado en 2013

Viremia profiles in hepatitis B virus carrier children with spontaneous e antigen seroconversion: a case of déjà vu?

artículo científico publicado en 2007

Vitamin D receptor gene polymorphisms and distinct clinical phenotypes of hepatitis B carriers in Taiwan.

artículo científico publicado en 2009

What can we learn from hepatitis B virus clinical cohorts?

artículo científico

Young Chronic Hepatitis B Patients With Nucleos(t)ide Analogue-induced Hepatitis B e Antigen Seroconversion Have a Higher Risk of HBV Reactivation

artículo científico publicado en 2012

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda